Prevalence of helicobacter pylori infection among type 2 diabetes mellitus
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttribution-NonCommercial-ShareAlike 4.0 Internationalhttps://creativecommons.org/licenses/by-nc-sa/4.0/Tarih
2020Yazar
Bener, AbdülbariAğan, Ahmet Faruk
Al-Hamaq, Abdulla Omar A.A.
Barışık, Cem Cahit
Öztürk, Mustafa
Ömer, Abdulkadir
Üst veri
Tüm öğe kaydını gösterKünye
Bener, A., Ağan, A. F., Al-Hamaq, A. O. A.A., Barışık, C. C., Öztürk, M. ve Ömer, A. (2020). Prevalence of helicobacter pylori infection among type 2 diabetes mellitus. Advanced Biomedical Research, 9(1). https://dx.doi.org/10.4103/abr.abr_248_19Özet
Background: Several conducted studies have reported a higher and more frequent Helicobacter pylori infection rate in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate the prevalence and its association between H. pylori infection and T2DM.Materials and methods: A case and control study was conducted based on 529 T2DM patients and 529 control. H. pylori was assessed by Serum anti-H. pylori immunoglobulin G (IgG) and IgA. Furthermore, patients were investigated for fasting blood glucose (FBG) levels, glycosylated hemoglobin (HbA1c), serum cholesterol, and other biochemistry parameters.Results: The findings showed a positive significantly higher antibody titer for H. pylori infection (IgA > 250) in diabetic patients (50.7%) compared to controls (38.2%) (P < 0.001). Similarly, H. pylori infection for IgG > 300 titer was higher in T2DM patients (73.5%) compared to controls 61.8%) (P < 0.001). Further, the mean values were statistically significant diabetes with H. pylori infection for IgG > 300 titer and IgA > 250 titer, regarding Vitamin D, HbA1C (P < 0.001), FBG, calcium, creatinine, total cholesterol, LHDL, triglyceride levels, uric acid, bilirubin, thyroid-stimulating hormone (TSH), and systolic and diastolic blood pressure. The diabetic patients showed higher prevalence rate of symptoms than controls included: hypertension (14.3%), vomiting (15.5%), muscular symptoms (35.2%), bloating/distension (13.2%), abdominal pain (17%), nausea (9.6%), anemia (17%), kidneys (20.8%), chronic bronchitis (14.7%), gastrointestinal (23.8%), and diarrhea (20.4%).Conclusions: The current study revealed that H. pylori infections were significantly higher in diabetic patients compared to controls. Furthermore, T2DM patients infected with H. pylori positive reported a higher prevalence rate of symptoms than H. pylori negative.
Kaynak
Advanced Biomedical ResearchCilt
9Sayı
1Koleksiyonlar
- Makale Koleksiyonu [361]
- PubMed İndeksli Yayınlar Koleksiyonu [4281]
- WoS İndeksli Yayınlar Koleksiyonu [6722]